论文部分内容阅读
作者在继发现微量元素锶(Sr)、钼(Mo)能强烈抑制肾草酸钙结晶及降低肾钙含量后,在重复试验成功的基础上将Sr用于实验性肾结石的预防及治疗。①防石模型的建立:结果对照组肾钙平均值为1.221±0.16mg/g,实验组为0.6359±0.34mg/g,经统计学处理P<0.05:在偏光显微镜下,Sr防石实验组肾脏切片每低倍视野中,每象限内见1～2个结石,而对照组可见20个结石。②实验性肾结石的治疗:结果两个治疗组的肾钙平均值均较对照组显著为低,P值分别<0.01和<0.001。治疗组之间的差别无显著意义。在
After the authors found that trace elements strontium (Sr) and molybdenum (Mo) could strongly inhibit the crystallinity of renal calcium oxalate and reduce the content of renal calcium, Sr was used for the prevention and treatment of experimental kidney stones based on the success of repeated experiments. 1The establishment of anti-stone model: The average value of renal calcium in the control group was 1.221±0.16 mg/g, and 0.6359±0.34 mg/g in the experimental group. Statistical analysis P<0.05: Sr anti-stone experimental group under polarized light microscope In each low power field of the kidney section, 1 to 2 stones were found in each quadrant, while 20 stones were seen in the control group. 2 Treatment of experimental kidney stones: Results The mean renal calcium in the two treatment groups was significantly lower than that in the control group, with P values <0.01 and <0.001, respectively. There was no significant difference between the treatment groups. in